Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
J Clin Oncol 2021 Mar 20
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002).
Related Questions
When, if ever, would you consider dose de-escalation for HPV-associated non-oropharyngeal HNSCC?
New answer
by Radiation Oncologist at American Cancer Center (June 21, 2023)
No. It is still investigational and not standard of care.
Read more (4 Answers available)
13853
×
To continue please login or register
Register
or
Sign in